NCT06840470View on ClinicalTrials.gov

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

March 11, 2027

Study Completion Date

September 11, 2027

Conditions
Sebaceous Hyperplasia
Interventions
DRUG

Imiquimod 5% Topical Cream

Participants will apply this cream to one side of the face 3 times a week for up to 8 weeks. The cream will be applied before bedtime. The imiquimod should be washed off with mild soap and water after 6-10 hours. Participants will have baseline and follow-up visits that will include photographs of the lesions.

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER